𝔖 Bobbio Scriptorium
✦   LIBER   ✦

177 Carboplatin(CBDCA) alone or in combination in the treatment of acute myeloid leukema (AML) secondary to myelodysplastic syndromes and in other high risk AML

✍ Scribed by L. Larrea; M.A. Sanz; G. Martin; J.A. Martinez; I. Jarque; C. Jiménez; G.F. Sanz

Book ID
114119380
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
118 KB
Volume
21
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine in combination with a standa
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial)
✍ Willemze, R.; Suciu, S.; Muus, P.; Halkes, C. J. M.; Meloni, G.; Meert, L.; Karr 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 197 KB